Ophthalmology · Laguna Hills, CA
NPI
1306026281
Since 2007
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
24401 Calle de la Louisa, Suite 300
Laguna Hills, CA, 92653
Phone (949) 951-2020
Groups this clinician bills Medicare through
Medicare paid, 2024
$885K
8,902 services
Medicare patients, 2024
1,604
Average age 78
Drug cost, 2024
$721K
3,041 prescriptions
Company payments, 2025
$110K
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Savak Teymoorian was code 92012 (ophthalmological e&m), 2,097 times for 1,272 patients. In total Savak Teymoorian billed 8,902 services in 29 codes, and Medicare paid $885K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-08-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92012 Ophthalmological E&M | Office | 2,097 | 1,272 | $67.57 | $142K |
| 92014 Ophthalmological E&M | Office | 1,351 | 1,094 | $96.81 | $131K |
| 92133 Computerized Ophthalmic Imaging | Office | 1,015 | 994 | $27.80 | $28K |
| 92083 Vision, Hearing, and Speech Services | Office | 835 | 822 | $48.85 | $41K |
| 92250 Angiography | Office | 738 | 725 | $29.21 | $22K |
| 92020 Ophthalmological E&M | Office | 510 | 485 | $22.37 | $11K |
| 68841 Eye | Facility | 472 | 273 | $13.67 | $6,450 |
| 66984 Cataract Surgery | Facility | 350 | 196 | $387.65 | $136K |
| 66030 Eye | Facility | 272 | 143 | $95.29 | $26K |
| 0660T Eye | Facility | 259 | 142 | $684.72 | $177K |
| 92136 Ultrasound - Nonspecific | Office | 211 | 206 | $35.41 | $7,472 |
| 92004 Ophthalmological E&M | Office | 195 | 195 | $111.42 | $22K |
| 76514 Ultrasound - Nonspecific | Office | 155 | 155 | $8.47 | $1,312 |
| 66821 Cataract Surgery | Office | 139 | 89 | $283.19 | $39K |
| 65855 Fluid Flow and Drainage of Eye (Any Method) | Office | 123 | 66 | $209.07 | $26K |
By year: 2022 $943K for 9,625 services; 2023 $793K for 8,811 services; 2024 $885K for 8,902 services.
Medicare prescription drug claims, 2024
In 2024, the drug Savak Teymoorian prescribed most often to Medicare patients was Latanoprost, with 674 prescriptions and refills. In total Savak Teymoorian wrote 3,041 Medicare prescriptions that cost $721K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 674 | 1,749 | 233 | $9,171 |
| Lumigan Bimatoprost | 451 | 966 | 147 | $269K |
| Timolol Maleate Generic | 337 | 766 | 95 | $9,290 |
| Prednisolone Acetate Generic | 204 | 225 | 147 | $6,661 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 186 | 365 | 49 | $2,712 |
| Prolensa Bromfenac Sodium | 108 | 116 | 79 | $36K |
| Brimonidine Tartrate Generic | 101 | 214 | 30 | $5,633 |
| Combigan Brimonidine Tartrate/Timolol | 97 | 233 | 34 | $53K |
| Rhopressa Netarsudil Mesylate | 81 | 126 | 20 | $40K |
| Polymyxin B Sul-Trimethoprim Polymyxin B Sulf/Trimethoprim | 74 | 79 | 60 | $493 |
| Alphagan P Brimonidine Tartrate | 73 | 150 | 25 | $37K |
| Dorzolamide Hcl Generic | 66 | 160 | 24 | $1,186 |
| Vyzulta Latanoprostene Bunod | 60 | 122 | 28 | $34K |
| Restasis Cyclosporine | 58 | 121 | 23 | $75K |
| Bromfenac Sodium Generic | 47 | 51 | 31 | $8,947 |
Brand drugs: 1,861 claims; generic drugs: 1,180 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Savak Teymoorian $110K ($110K in general payments such as food, travel and fees) from 11 companies. The largest payer was Glaukos Corporation with $94K.
| Company | Payments | Amount |
|---|---|---|
| Glaukos Corporation GKOS | 45 | $94K |
| Abbvie Inc. ABBV | 54 | $16K |
| Alcon Vision LLC ALC | 28 | $712 |
| Tarsus Pharmaceuticals, Inc. TARS | 3 | $83.08 |
| Thea Pharma Inc. | 3 | $65.22 |
| Ocular Therapeutix, Inc. OCUL | 3 | $54.73 |
| Bausch & Lomb Americas Inc. BLCO | 3 | $53.56 |
| Johnson & Johnson Surgical Vision, Inc. JNJ | 1 | $41.71 |
| Biotissue Holdings Inc. | 1 | $25 |
| Nova Eye, Inc. | 1 | $24.75 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.